An immunophenotypic pre-treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34+ CD38 low blasts

Many older patients with acute myeloid leukaemia (AML) that receive standard intensive chemotherapy fail to achieve complete remission (CR). Upfront identification of patients unlikely to benefit from standard induction chemotherapy would be important for exploration of novel therapies. This study e...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	British journal of haematology 2015-07, Vol.170 (1), p.80-84
Hauptverfasser:	Khan, Naeem, Freeman, Sylvie D, Virgo, Paul, Couzens, Steve, Richardson, Peter, Thomas, Ian, Grech, Angela, Vyas, Paresh, Grimwade, David, Russell, Nigel H, Burnett, Alan K, Hills, Robert K
Format:	Artikel
Sprache:	eng
Schlagworte:	ADP-ribosyl Cyclase 1 - blood Aged Aged, 80 and over Antigens, CD34 - blood Flow Cytometry Humans Immunophenotyping Induction Chemotherapy Leukemia, Myeloid, Acute - blood Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - pathology Middle Aged Prognosis Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!